Professor Erika Lietzan was recently quoted by CBS News in a Moneywatch article relating to pharmaceutical manufacturing, “Drugmaker behind ibuprofen recall has history of FDA violations.”

Last month New Jersey drugmaker Tris Pharma doubled its recall of infant ibuprofen, and CBS News spoke with Professor Lietzan about the company’s manufacturing history.  She described some of the “red flags” in a warning letter that Tris Pharma received in March 2018 and noted a potential systemic problem for the company to address.

Before joining Mizzou Law in 2014, Professor Lietzan was a partner in the food and drug group of Covington & Burling LLP in Washington DC, where (among other things) she advised drug companies on compliance with current good manufacturing practices and helped them respond to enforcement actions. She now teaches Regulation of Drugs and Devices at the law school.